• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MC3 INC. NAUTILUS; ECMO OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MC3 INC. NAUTILUS; ECMO OXYGENATOR Back to Search Results
Model Number 48145
Medical Device Problem Code Partial Blockage (1065)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 08/13/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Mc3 investigated the returned product.That had clotted off and required device exchange.The root cause of low flow performance ot the oxygenator and device change-out is believed to be a blood clot in the fiber bundle created by an upstream circuit source, possibly the pumphead or patient based on the following: customer stated there was an abrupt drop in flow at approximately 6am, 4.5 hours after the start of procedure.According to records, the device performed as expected for 4.5 hours which describes normal function.No observation of clots in circuit prior to 6am.Oxygenator adjustments would have been made if there was an obstruction preventing flow, prior to 6am.The abrupt drop in flow indicates the clot suddenly entered the fiber bundle, inhibiting flow and causing change-out.Customer described that the pumphead " felt hot" which has an unknown impact.The pump was not retained so could not be investigated.An impella device was also used in this patient with unknown impact.This is believed to be an isolated incident with no impact to production or product in the field.
 
Event or Problem Description
Distributor received information that during use of a mc3 nautilus oxygenator, there was difficulty maintaining flow above 0.5 l/min.The system/pump/circuit was changed out for cardiohelp.And the flow improved to 3.5-4.0 l/min.It was suspected that the nautilus clotted off.The ap40 centrifugal pump was part of the circuit.Additional information from the sales rep: the patient was on fem -fem va extracorporeal membrane oxygenation (ecmo).The patient had been placed on support on (b)(6) 2020 at 01:29.Rpm: 3070, flow: 4.3l/min new flow with cardiohelp: 4.0l/min, 3665rpm.Cardiac patient placed on fem-fem va ecmo and impella for support.Drainage lt fem ven: 24fr edwards reinfusion lt fem art: 18fr edwards loading dose of heparin was 5,000, no heparin after.Pt: 22, inr: 2.1, aptt: 90.2.An adapter was not used with the ap40, it was mounted directly in the bio-console.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAUTILUS
Common Device Name
ECMO OXYGENATOR
Manufacturer (Section D)
MC3 INC.
2555 bishop circle west
dexter MI 48130
MDR Report Key10525491
Report Number3011468686-2020-00005
Device Sequence Number14465981
Product Code BYS
UDI-Device Identifier10854916006888
UDI-Public10854916006888
Combination Product (Y/N)N
PMA/510(K) Number
K191935
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source distributor,health profession
Type of Report Initial
Report Date (Section B) 08/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/31/2022
Device Model Number48145
Device Catalogue Number48145
Device Lot Number2005164
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/19/2020
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/14/2020
Initial Report FDA Received Date09/11/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age59 YR
-
-